ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Xugang Sun
Matched on OpenAlex author ID A5050833382. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jss.2024.12.047↗
- Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling. Co-author DOI 10.1136/gutjnl-2024-333638↗
- Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study. Co-author DOI 10.3389/fonc.2023.1276037↗
- PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. First author DOI 10.1016/j.canlet.2021.05.021↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chuntao Gao · 4 shared papers, 2021–2025 · strength 0.74
- Paper Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jss.2024.12.047↗
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic canc… DOI 10.3389/fonc.2023.1276037↗
- Tiansuo Zhao · 4 shared papers, 2021–2025 · strength 0.74
- Paper Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jss.2024.12.047↗
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic canc… DOI 10.3389/fonc.2023.1276037↗
- Haorui Li · 3 shared papers, 2023–2025 · strength 0.63
- Paper Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jss.2024.12.047↗
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic canc… DOI 10.3389/fonc.2023.1276037↗
- Wenrun Cai · 2 shared papers, 2021–2025 · strength 0.31
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Jihui Hao · 2 shared papers, 2021–2025 · strength 0.31
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Xiuchao Wang · 2 shared papers, 2021–2023 · strength 0.28
- Paper Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic canc… DOI 10.3389/fonc.2023.1276037↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Song Gao · 2 shared papers, 2021–2023 · strength 0.28
- Paper Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic canc… DOI 10.3389/fonc.2023.1276037↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Yuexiang Liang · 1 shared paper, 2025 · strength 0.26
- Yu Guo · 1 shared paper, 2025 · strength 0.26
- Shengyu Yang · 1 shared paper, 2025 · strength 0.20
- Danqi Fu · 1 shared paper, 2025 · strength 0.20
- Shaofei Chang · 1 shared paper, 2023 · strength 0.17
- Fanjie Jin · 1 shared paper, 2021 · strength 0.11
- Chongbiao Huang · 1 shared paper, 2021 · strength 0.11
- Huizhi Sun · 1 shared paper, 2021 · strength 0.11
- Jing Liu · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.